Siva Sakhamuri Chief Technology Officer

Siva joins Orna Therapeutics as Chief Technology Officer and brings significant experience in pharmaceutical manufacturing. He has broad experience in clinical and commercial biologics, small molecule and vaccine manufacturing, CMC strategy, process development, external vendor/alliance and project management, regulatory support, and life cycle product management. Prior to Orna, Siva was Senior Vice President, Head of Technical Operations and Quality at Omega Therapeutics and Vice President, Head of Manufacturing for Alnylam’s internal and external manufacturing operations, including seminal contributions to the registration and launch of Onpattro^®, Givlaari^®, and Oxlumo^®. Before Alnylam, he was Executive Director, Global Tech Services, Process and Analytical Development at Alexion Pharmaceuticals, and earlier was Director of Manufacturing for Sanofi-Pasteur, where he was responsible for commercial vaccine product manufacturing and facility management. Siva began his industry career at Bristol-Myers Squibb Co. supporting global biologics manufacturing teams. He received his Ph.D. in Biochemical Engineering from Indian Institute of Technology, completed a Postdoctoral Fellowship at the Korea Research Institute of Bioscience & Biotechnology and additional postdoctoral research at Hong Kong University of Science and Technology and Pennsylvania State University.